May 5
CCCC · C4 Therapeutics, Inc. · Documents
$2.77
-0.12 (-4.15%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$363.75M
Shares
131.32M
Volume · Nov 12
4.97M
Avg daily vol (3M)
2.53M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Apr 29
Proxy statement
DEF 14A
Meeting Jun 22, 2022
Proxy statement
Apr 29
Proxy statement
DEFA14A
Proxy statement
Apr 8
Current report
8-K
Other events
Mar 16
Current report
8-K
Events of Mar 10
Director or officer change, or executive pay, Regulation FD disclosure
Feb 24
Current report
8-K
Financial results
Feb 24
Jan 21
Current report
8-K/A
Events of Jan 10
Current report
Jan 10
Current report
8-K
Financial results, Regulation FD disclosure
2021
Nov 30
Current report
8-K
Events of Nov 24
Entered into a material agreement, New debt or off-balance-sheet obligation
Nov 10
Current report
8-K
Financial results
Nov 10
Nov 10
Registration statement
S-3ASR
Registration statement
Aug 11
Current report
8-K
Financial results, Regulation FD disclosure
Aug 11
Jun 21
Current report
8-K
Events of Jun 15
Shareholder vote results, Regulation FD disclosure
Jun 14
Current report
8-K
Other events
Jun 14
Registration statement
S-1
Registration statement
Jun 7
Current report
8-K
Other events
May 26
Current report
8-K
Regulation FD disclosure
May 20
Current report
8-K
Director or officer change, or executive pay
May 13
Current report
8-K
Financial results
May 13
Apr 30
Current report
8-K
Events of Apr 27
Director or officer change, or executive pay
Apr 26
Proxy statement
DEF 14A
Meeting Jun 15, 2021
Proxy statement
Apr 26
Proxy statement
DEFA14A
Proxy statement
Mar 11
Current report
8-K
Events of Mar 10
Financial results, Director or officer change, or executive pay
Mar 11
Jan 12
Current report
8-K
Events of Jan 6
Financial results, Regulation FD disclosure
Jan 6
Current report
8-K
Regulation FD disclosure
2020
Nov 19
Current report
8-K
Events of Nov 18
Regulation FD disclosure
Nov 12
Current report
8-K
Financial results
Nov 12
Oct 6
Current report
8-K
Events of Oct 1
Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change
Sep 28
Registration statement
S-1/A
Registration statement
Sep 10
Registration statement
S-1
Registration statement
Showing 101–136 of 136 documents
Key facts
CIK
1662579
CUSIP
12529R107
13F (30d)
75 filings
62 filers
Visit website
Investor relations